Predictive value of preclinical models for CAR-T cell therapy clinical trials: a systematic review and meta-analysis
Background Experimental mouse models are indispensable for the preclinical development of cancer immunotherapies, whereby complex interactions in the tumor microenvironment can be somewhat replicated. Despite the availability of diverse models, their predictive capacity for clinical outcomes remains...
Saved in:
| Main Authors: | Sebastian Kobold, Carsten Marr, David Andreu-Sanz, Lisa Gregor, Emanuele Carlini, Daniele Scarcella |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/6/e011698.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term consequences of cancer therapy: cognitive impairment following CAR T cell therapy
by: Kathrin Gabriel, et al.
Published: (2025-07-01) -
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy
by: C. Carcopino, et al.
Published: (2024-12-01) -
Challenges in the preclinical design and assessment of CAR-T cells
by: Radu Tomai, et al.
Published: (2025-08-01) -
Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies
by: Sebastian Kobold, et al.
Published: (2010-01-01) -
Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma
by: Oula K. Dagher, et al.
Published: (2025-09-01)